Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Tandem Diabetes Care

Tandem Diabetes Care Scores Relative Strength Rating Upgrade; Hits Key Threshold

Tandem Diabetes Care sees its Relative Strength Rating reach the 80-plus level.

Investors Business Daily

Tandem Diabetes Care Clears Key Benchmark, Hitting 80-Plus RS Rating

Tandem Diabetes Care Clears Key Benchmark, Hitting 80-Plus RS Rating

A Relative Strength Rating upgrade for Tandem Diabetes Care shows improving technical performance.

Investors Business Daily

Tandem Diabetes Care Reaches 80-Plus Relative Strength Rating Benchmark

Tandem Diabetes Care Reaches 80-Plus Relative Strength Rating Benchmark

Tandem Diabetes Care sees its Relative Strength Rating enter the 80-plus level.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Tandem Diabetes Care Stock Belongs On Your Watchlist As RS Rating Jump Higher

A Relative Strength Rating upgrade for Tandem Diabetes Care shows improving technical performance. Will it continue?

Investors Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2022

6 Analysts Have This to Say About Tandem Diabetes Care

Within the last quarter, Tandem Diabetes Care (NASDAQ:TNDM) has observed the following analyst ratings:

Recap: Tandem Diabetes Care Q1 Earnings

Tandem Diabetes Care (NASDAQ:TNDM) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

inkl

Read news from The Economist, FT, and more,
with one subscription

Expert Ratings For Tandem Diabetes Care

Expert Ratings For Tandem Diabetes Care

Over the past 3 months, 4 analysts have published their opinion on Tandem Diabetes Care (NASDAQ:TNDM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Tandem Diabetes Care: Q4 Earnings Insights

Tandem Diabetes Care: Q4 Earnings Insights

Tandem Diabetes Care (NASDAQ:TNDM) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

1

Organisations

Bed, Bath & Beyond

Palantir Technologies

Charter Communications

Crispr rapeutics

Winnebago Industries

Myovant Sciences

Global Blood rapeutics

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play